Pharmaceuticals, Biotechnology and Life Sciences
MELBOURNE, Australia and INDIANAPOLIS, Jan. 31, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company)…
Diag-Nose.io sets new standards in respiratory care with AI and proteomics after a $2M seed funding success, now expanding to…
Diag-Nose.io launches Houston office to advance precise respiratory care using AI and proteomics after a successful $2M seed roundHOUSTON, Jan.…
Diag-Nose.io, a Stanford EENT Innovation graduate, secures $2M in oversubscribed seed funding to revolutionize respiratory care with precise, AI-driven diagnostics…
Conference call scheduled for 8:00 a.m. Eastern TimeWALTHAM, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a…
DOVER, Del., Jan. 30, 2025 (GLOBE NEWSWIRE) — Portage Biotech, Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology…
SAN CARLOS, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity…
TUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
RADNOR, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today…